Marina Wolfson - 29 Oct 2023 Form 4 Insider Report for BiomX Inc. (PHGE)

Role
Chief Financial Officer
Signature
/s/ Marina Wolfson
Issuer symbol
PHGE
Transactions as of
29 Oct 2023
Net transactions value
$0
Form type
4
Filing time
31 Oct 2023, 17:10:52 UTC
Previous filing
03 Mar 2023
Next filing
13 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHGE Common Stock Options - Right to Buy Award $0 +59,800 $0.000000 59,800 29 Oct 2023 Common Stock 0 $0.2750 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest and become exercisable over four years, with 25% of the shares subject to the option vesting on October 29, 2024, and the remainder vesting in 12 equal quarterly installments over three years.